
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 0.550 | 0.560 | 0.010 |
Shares | 99.320 | 99.320 | 0.000 |
Preferred | 0.100 | 0.100 | 0.000 |
Other | 0.030 | 0.030 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 19.404 | 17.834 |
Price to Book | 3.873 | 3.321 |
Price to Sales | 2.616 | 2.204 |
Price to Cash Flow | 16.365 | 13.809 |
Dividend Yield | 2.475 | 2.916 |
5 Years Earnings Growth | 20.156 | 10.937 |
Name | Net % | Category Average |
---|---|---|
Healthcare | 33.750 | 30.790 |
Financial Services | 27.010 | 21.679 |
Industrials | 21.580 | 15.838 |
Consumer Defensive | 7.850 | 12.716 |
Basic Materials | 6.790 | 8.187 |
Technology | 1.770 | 3.418 |
Consumer Cyclical | 1.240 | 5.346 |
Number of long holdings: 60
Number of short holdings: 18
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Novartis | CH0012005267 | 7.16 | 96.18 | +0.17% | |
UBS Group | CH0244767585 | 7.10 | 26.78 | +1.36% | |
Roche Holding Participation | CH0012032048 | 6.77 | 261.60 | -0.19% | |
ABB | CH0012221716 | 6.66 | 47.79 | +4.28% | |
Nestle | CH0038863350 | 5.51 | 79.29 | +0.38% | |
Zurich Insurance Group | CH0011075394 | 5.47 | 555.20 | +0.29% | |
Alcon | CH0432492467 | 4.45 | 70.36 | +0.49% | |
Lonza Group | CH0013841017 | 3.84 | 566.60 | +0.60% | |
Swiss Re | CH0126881561 | 3.71 | 137.35 | +0.59% | |
Partners Group | CH0024608827 | 3.08 | 1,030.00 | +2.03% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
UBAM Swiss Eq RC CHF | 1.79B | 5.47 | 1.83 | 3.94 | ||
UBAM Swiss Eq AHC CHF | 1.73B | 2.28 | -0.13 | - | ||
UBAM Swiss Eq AHD CHF | 1.73B | 2.27 | -0.13 | - | ||
UBAM Swiss Eq IHC CHF | 1.73B | 2.41 | 0.26 | - |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review